{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:48Z","timestamp":1772121708817,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.02.076","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T17:48:22Z","timestamp":1583516902000},"page":"3255-3260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates"],"prefix":"10.1016","volume":"38","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1607-2733","authenticated-orcid":false,"given":"Barbara","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigori","family":"Cheguelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2020.02.076_b0005","first-page":"383","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterology","volume":"3","author":"Polaris Observatory Collaborators","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2020.02.076_b0010","unstructured":"World Health Organisation. Global health sector strategy on viral hepatitis 2016-2021 2016 [Available from: https:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/."},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.076_b0015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3201\/eid2309.161594","article-title":"Use of blood donor screening to monitor prevalence of HIV and hepatitis B and C viruses, South Africa","volume":"23","author":"Vermeulen","year":"2017","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.076_b0020","unstructured":"World Health Organisation. HBV overview 2018 [Available from: http:\/\/www.who.int\/hepatitis\/news-events\/hbv-cure-overview\/en\/."},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1753-6405.12693","article-title":"Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013\u201315","volume":"42","author":"MacLachlan","year":"2018","journal-title":"Australia New Zealand J Public Health"},{"issue":"13","key":"10.1016\/j.vaccine.2020.02.076_b0030","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1017\/S0950268814003914","article-title":"Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys","volume":"143","author":"Gidding","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.02.076_b0035","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.drugalcdep.2006.09.022","article-title":"Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users","volume":"91","author":"Campbell","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.076_b0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: A scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1467-9566.2007.00474.x","article-title":"Unhealthy prisons: exploring structural determinants of prison health","volume":"29","author":"de Viggiani","year":"2007","journal-title":"Sociol Health Illn"},{"key":"10.1016\/j.vaccine.2020.02.076_b0050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.02.076_b0055","series-title":"National prison entrants' blood-borne virus survey report 2004, 2007, 2010, 2013, and 2016","author":"Butler","year":"2017"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.076_b0060","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.vaccine.2012.01.020","article-title":"Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003\u20132010: a retrospective ecological study","volume":"30","author":"Beck","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2020.02.076_b0065","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.vaccine.2005.11.055","article-title":"Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales","volume":"24","author":"Sutton","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.076_b0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvh.12701","article-title":"Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005\u20132014: The HITS-p study","volume":"24","author":"Cunningham","year":"2017","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.vaccine.2020.02.076_b0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/1471-2458-10-777","article-title":"HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis","volume":"10","author":"Gough","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2020.02.076_b0080","series-title":"HIV, viral hepatitis and sexually transmissable infections in Australia. Annual surveillance report 2018","author":"The Kirby Institute","year":"2018"},{"key":"10.1016\/j.vaccine.2020.02.076_b0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drugpo.2017.12.013","article-title":"Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study","volume":"54","author":"Cunningham","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.vaccine.2020.02.076_b0090","series-title":"2009 NSW Inmate health survey: Key findings report","author":"Indig","year":"2010"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.076_b0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1753-6405.2012.00881.x","article-title":"Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney","volume":"36","author":"White","year":"2012","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2020.02.076_b0100","first-page":"1","article-title":"Hepatitis B Seroepidemiology in Australia, One Decade After Universal Vaccination of Infants and Adolescents","volume":"18","author":"Xinting","year":"2018","journal-title":"Infect Disord \u2013 Drug Targ"},{"key":"10.1016\/j.vaccine.2020.02.076_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-0711-2-10","article-title":"Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity","volume":"2","author":"Salto\u011flu","year":"2003","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.076_b0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40620-017-0443-5","article-title":"The accelerated HBV vaccination schedule among hemodialysis patients, does it work? A randomized controlled trial","volume":"30","author":"Imam","year":"2017","journal-title":"J Nephrol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.02.076_b0115","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/656776","article-title":"Accelerated Hepatitis B Vaccination Schedule among Drug Users: A Randomized Controlled Trial","volume":"202","author":"Hwang","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.076_b0120","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.2105\/AJPH.2014.302487","article-title":"Long-Term Effectiveness of Accelerated Hepatitis B Vaccination Schedule in Drug Users","volume":"105","author":"Shah","year":"2015","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.076_b0125","doi-asserted-by":"crossref","first-page":"e0133464","DOI":"10.1371\/journal.pone.0133464","article-title":"Comparison of accelerated and standard hepatitis B vaccination schedules in high-risk healthy adults: A meta-analysis of randomized controlled trials","volume":"10","author":"Jin","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/add.13944","article-title":"Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs","volume":"113","author":"Palmateer","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vaccine.2016.11.041","article-title":"Vaccination against hepatitis B virus among people who inject drugs \u2013 A 20 year experience from a Swedish needle exchange program","volume":"35","author":"Alanko Blom\u00e9","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.puhe.2005.03.017","article-title":"Prevention of infectious disease transmission in correctional settings: a review","volume":"120","author":"Niveau","year":"2006","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/epirev\/mxy001","article-title":"Active case finding for communicable diseases in prison settings: Increasing testing coverage and uptake among the prison population in the European Union\/European Economic Area","volume":"40","author":"Tavoschi","year":"2018","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2020.02.076_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40352-017-0055-0","article-title":"The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care","volume":"5","author":"Hochstatter","year":"2017","journal-title":"Health Justice"},{"key":"10.1016\/j.vaccine.2020.02.076_b0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2015.11.031","article-title":"Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial","volume":"74","author":"Day","year":"2016","journal-title":"J Clin Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.02.076_b0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1473-3099(07)70237-2","article-title":"Vaccine immunogenicity in injecting drug users: a systematic review","volume":"7","author":"Baral","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2020.02.076_b0170","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.vaccine.2017.03.034","article-title":"Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial","volume":"35","author":"Shi","year":"2017","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2020.02.076_b0175","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.vaccine.2014.02.072","article-title":"Immune response to hepatitis B vaccination in drug using populations: A systematic review and meta-regression analysis","volume":"32","author":"Kamath","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2020.02.076_b0180","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1440-1746.2004.03438.x","article-title":"Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney","volume":"19","author":"Maher","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.076_b0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00365540310018833","article-title":"Progressive decrease of hepatitis B in a cohort of drug users followed over a period of 15 years: the impact of anti-HBV vaccination","volume":"36","author":"Lugoboni","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2020.02.076_b0190","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system \u2013 friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.076_b0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/epirev\/mxy003","article-title":"HIV and viral hepatitis among imprisoned key populations","volume":"40","author":"Wirtz","year":"2018","journal-title":"Epidemiol Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2020.02.076_b0200","doi-asserted-by":"crossref","first-page":"e67866","DOI":"10.1371\/journal.pone.0067866","article-title":"Selective hepatitis B virus vaccination has reduced HBV transmission in The Netherlands","volume":"8","author":"Hahn\u00e9","year":"2013","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.076_b0205","doi-asserted-by":"crossref","first-page":"e0145022","DOI":"10.1371\/journal.pone.0145022","article-title":"Cost-effectiveness of HBV and HCV screening strategies \u2013 A systematic review of existing modelling techniques","volume":"10","author":"Geue","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:34Z","timestamp":1759401754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303200"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.076","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737530611.793572441","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}